top of page

RGCC ONCONOMICS

RGCC Onconomics – Personalized Cancer Treatment Guidance

A comprehensive test that analyzes how your cancer cells respond to specific treatments, helping you make smarter therapy decisions

Onconomics is a personalized cancer profiling test developed by RGCC Group — a global leader in precision oncology. Using a sample of your blood, the test analyzes circulating tumor cells (CTCs) and evaluates which treatments (chemotherapy, targeted therapies, and natural substances) are most effective against your specific cancer profile.

This helps doctors avoid trial-and-error treatments and select options that are scientifically matched to your cancer’s behavior.

Benefits of RGCC Onconomics Test

Precision treatment matching for your unique cancer profile

Minimizes guesswork and unnecessary side effects

Includes both conventional drugs and natural compounds

Supports integrative oncology and personalized healing

Empowers patients and doctors to choose smarter, more targeted therapies

Can save time, cost, and emotional stress in the treatment journey

What to Expect

Blood draw performed by our doctor

Sample is sent to RGCC’s advanced lab in Europe

Results typically available in 2–3 weeks

Includes doctor consultation to explain results and support treatment planning

Take the Guesswork Out of Cancer Treatment

Whether you're newly diagnosed or exploring advanced options, Onconomics helps take control back into your hands — with a science-backed roadmap tailored to your biology

bottom of page